ITOC logo

ITONIC HOLDINGS LTD

ITOCNASDAQ
🏆 #4602 by market capUS Equity
$2.75▲ $0.18 (+7.00%)
Pre-market · at close
🔔
Track ITOC
Get earnings, price moves & breaking news on Telegram
Track
24h▲ 7.0%
7d▼ 19.4%
14d▼ 26.0%
30d▼ 36.8%
ytd▼ 60.1%
1y▼ 73.8%
🏦Market Cap
$20M
Small Cap
📈Revenue Growth (YoY)
82.3%
High Growth
📊Gross Margin
60.9%
High
💵FCF Margin
—
⚖️P/S Ratio
34.8x
Expensive
Otter Score
—
Insufficient data

Trading Snapshot

Day Range
$2.75 – $2.75
52-Week Range
$2.33 – $18.40
Volume (shares)
156
Avg Volume (shares)
—
Shares Outstanding
7.3M
Next Earnings
—

Fundamentals Snapshot

Annual Revenue
$523,031
Last Q Revenue
$100,906
P/E Ratio
—
P/S Ratio
34.8x
EPS (TTM)
$-4.17
Dividend Yield
—
Dilution (1yr)
+17.9%
ITOC logo

ITONIC HOLDINGS LTD

ITOC
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$523K▲ +16.7% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
62.6%▼ −18.7% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$5M▲ +573.4% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$3M▲ +318.1% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
1.1M▲ +17.9% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$1M▼ −$5M YoY
StockOtter · stockotter.space

About ITONIC HOLDINGS LTD

iTonic Holdings Ltd., a healthcare solutions firm, specializes in the development and commercialization of software and devices for brachytherapy. Its advanced proprietary treatment planning system centers on radioactive particle implantation, a form of radiotherapy employed in cancer treatment to precisely position radioactive sources within patients, thereby eradicating malignant cells and reducing tumor size. Key among its offerings is FTTPS, a sophisticated treatment planning system engineered for diverse malignant tumors. This system excels at defining the target volume, determining the prescribed dose, establishing safety margins for organs at risk, and formulating a precise dose distribution plan essential for brachytherapy patients. Founded in Beijing, China, in 1998, the company operated as Pheton Holdings Ltd. until its rebranding to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. functions as a subsidiary of ZJW (BVI) LTD.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
💧Dilution★★★★★
Overall Score
Insufficient data
—/100
Analyst data unavailable.

Latest News & Updates

News unavailable.